Konstantinos k. (@c_kelep) 's Twitter Profile
Konstantinos k.

@c_kelep

PhD student at @LiccardiLab Institute of Biochemistry, University of Cologne

ID: 1443506689358106625

calendar_today30-09-2021 09:23:19

5 Tweet

60 Takipçi

245 Takip Edilen

LiccardiLab (@liccardilab) 's Twitter Profile Photo
LiccardiLab
@liccardilab

4 years ago

Fantastic day for the Walczak lab and the LiccardiLab currently at the 18th TNF conference in Switzerland

Fantastic day for the Walczak lab and the <a href="/LiccardiLab/">LiccardiLab</a> currently at the 18th TNF conference in Switzerland
Gianmaria Liccardi (@giammy_l) 's Twitter Profile Photo
Gianmaria Liccardi
@giammy_l

a year ago

Incredibly proud of our first paper in CDD press on pMLKL-s345 . Congrats Konstantinos k. for driving this project. BIG Thank you to all our collaborators Alessandro Annibaldi Andreas Linkermann Walczak Lab Pardo Galvez Lab for your incredible support and input. nature.com/articles/s4141…

Gianmaria Liccardi (@giammy_l) 's Twitter Profile Photo
Gianmaria Liccardi
@giammy_l

a year ago

Celebration time for the LiccardiLab . Once again congratulations Konstantinos k. for your paper. #goodtimes Debora Bonasera Hassan Rakhsh-Khorshid Julia Saggau Anne Berghaus Мижиддорж

Celebration time for the <a href="/LiccardiLab/">LiccardiLab</a> . Once again congratulations <a href="/c_kelep/">Konstantinos k.</a> for your paper. #goodtimes <a href="/DeboraBonasera/">Debora Bonasera</a> <a href="/HassanRK_13/">Hassan Rakhsh-Khorshid</a> <a href="/julia_saggau/">Julia Saggau</a> <a href="/Berghausanne/">Anne Berghaus</a> <a href="/mijee0705/">Мижиддорж</a>
Walczak Lab (@walczak_lab) 's Twitter Profile Photo
Walczak Lab
@walczak_lab

a year ago

Very excited about our recent publication in Cell Death & Differentiation Springer Nature Many thanks to all contributors and the great collaboration! #ucl #UniCologne #NDMC #UniStuttgart #IISAragón nature.com/articles/s4141…

Walczak Lab (@walczak_lab) 's Twitter Profile Photo
Walczak Lab
@walczak_lab

9 months ago

Promising new treatment approach for severe COVID-19! Clinical trial with Fas ligand blocker shows faster recovery & reduced mortality. Approach targets immune overreaction, potentially effective against future viruses too. #COVID19 #Science #PublicHealth t.ly/6kalU